Clinical Portrait of the SARS-CoV-2 Epidemic in European Patients with CancerDavid J. Pinato, Javier Marco‐Hernández, Daniele Generali et al.|Cancer Discovery|2020Cited by 183
Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the OnCovid retrospective, multicentre registry studyDavid J. Pinato, David García-Illescas, Josep Tabernero et al.|The Lancet Oncology|2021Cited by 136
Outcomes of the SARS-CoV-2 omicron (B.1.1.529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe: results from the retrospective, multicentre, OnCovid registry studyDavid J. Pinato, Enrico Caliman, Daniela Ferrante et al.|The Lancet Oncology|2022Cited by 80
Time-Dependent COVID-19 Mortality in Patients With CancerOnCovid study group, Ariadna Roqué, David J. Pinato et al.|JAMA Oncology|2021Cited by 72
Determinants of enhanced vulnerability to coronavirus disease 2019 in UK patients with cancer: a European studyDavid J. Pinato, Yien Ning Sophia Wong, Lorenza Scotti et al.|European Journal of Cancer|2021Cited by 51